4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-21-037478
Chief Scientific Officer sold 21,790 shares at an average $21.64 ($471,437)
- Chief Scientific Officer acquired 50,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Monahan Joseph Chief Scientific Officer | 2021-06-01 | Option exercise | +50,000 | 107,132 | D: show line 1 in the form | ||
| Monahan Joseph Chief Scientific Officer | 2021-06-02 | Sale | −18,240 | $21.50 | $392,231 | 88,892 | D: show line 2 in the form |
| Monahan Joseph Chief Scientific Officer | 2021-06-02 | Sale | −3,550 | $22.31 | $79,205 | 85,342 | D: show line 3 in the form |
| Open-market sales · 21,790 sh · avg $21.64 · $471,437 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Monahan Joseph Chief Scientific Officer | 2021-06-01 | Option exercise · Restricted Stock Units | −50,000 | 0 | D: show line 4 in the form |
Loading xslF345X03/doc4.xml…